Ad is loading...
MENU

EXEL Exelixis Forecast, Technical & Fundamental Analysis

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology
EXEL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
EXEL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EXEL is expected to report earnings to fall 19.62% to 37 cents per share on February 11

Exelixis EXEL Stock Earnings Reports
Q4'24
Est.
$0.38
Q3'24
Beat
by $0.13
Q2'24
Beat
by $0.53
Q1'24
Missed
by $0.06
Q4'23
Beat
by $0.10
The last earnings report on October 29 showed earnings per share of 46 cents, beating the estimate of 34 cents. With 1.76M shares outstanding, the current market capitalization sits at 10.17B.
A.I. Advisor
published General Information

General Information

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
1310
Web
https://www.exelixis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DWAS102.692.00
+1.99%
Invesco Dorsey Wright SmallCap Momt ETF
YALL40.190.56
+1.42%
God Bless America ETF
KONG30.780.34
+1.12%
Formidable Fortress ETF
DFAC36.060.24
+0.67%
Dimensional US Core Equity 2 ETF
CAOS87.13-0.06
-0.07%
Alpha Architect Tail Risk ETF

EXEL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EXEL has been loosely correlated with SRPT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if EXEL jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXEL
1D Price
Change %
EXEL100%
+2.24%
SRPT - EXEL
36%
Loosely correlated
+3.38%
ALNY - EXEL
34%
Loosely correlated
-0.77%
TECH - EXEL
33%
Poorly correlated
+0.32%
MRSN - EXEL
32%
Poorly correlated
+3.03%
ORMP - EXEL
32%
Poorly correlated
+1.30%
More